Articles by Jim Miller - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jim Miller

A Look Ahead for 2010

Some predictions for contract services in 2010.
Jan 2, 2010

Some predictions for contract services in 2010.

The year ahead

Some predictions about what's in store for contract services in 2010.
Jan 1, 2010

It's customary among columnists to begin a new year with some predictions about what's to come. We don't honour that custom every year, but with what the contract services industry went through in 2009, it seemed appropriate to share thoughts on what we expect for 2010.

Squeezed for Cash

Big Pharma's efforts to reduce working capital will hurt CMOs for years to come.
Dec 2, 2009

Big Pharma's efforts to reduce working capital will hurt CMOs for years to come.

Facing Reality

Contract organizations waiting for the pipeline to come roaring back are kidding themselves.
Dec 2, 2009

Contract organizations waiting for the pipeline to come roaring back are kidding themselves.

Squeezed for cash

Big Pharma's efforts to reduce working capital will hurt CMOs for years to come.
Dec 1, 2009

Big Pharma's efforts to reduce working capital will hurt CMOs for years to come.

The Outlook for Contract Services: Is That Light at the End of the Tunnel?

Nov 24, 2009

View Jim Miller's presentation from the AAPS 2009 Meeting and Exhibition.

Sizing Up the CDMO Market

A new analysis highlights growth drivers and challenges for clinical supply-chain services.
Nov 10, 2009

A new analysis highlights growth drivers and challenges for clinical supply-chain services.

Facing Reality

Contract organizations waiting for the pipeline to come roaring back are kidding themselves.
Nov 2, 2009

Contract organizations waiting for the pipeline to come roaring back are kidding themselves.

Reality not insanity

CDMOs waiting for the pipeline to come roaring back are kidding themselves.
Nov 1, 2009

Apopular definition of insanity is repeating the same task over and over again while expecting a different result. It would appear, therefore, that many people in the contract services industry think the major global bio/pharma companies are insane.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search
Click here